Annual ROA
-98.12%
-28.51%-40.96%
December 31, 2022
Summary
- As of March 4, 2025, SRNE annual return on assets is -98.12%, with the most recent change of -28.51% (-40.96%) on December 31, 2022.
- During the last 3 years, SRNE annual ROA has fallen by -48.69% (-98.50%).
- SRNE annual ROA is now -4580.37% below its all-time high of 2.19%, reached on December 31, 2017.
Performance
SRNE ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-103.91%
+6.69%+6.05%
June 30, 2023
Summary
- As of March 4, 2025, SRNE quarterly return on assets is -103.91%, with the most recent change of +6.69% (+6.05%) on June 30, 2023.
- Over the past year, SRNE quarterly ROA has increased by +6.69% (+6.05%).
- SRNE quarterly ROA is now -4759.64% below its all-time high of 2.23%, reached on December 31, 2017.
Performance
SRNE Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
SRNE ROA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -41.0% | +6.0% |
3 y3 years | -98.5% | +6.0% |
5 y5 years | -4580.4% | +6.0% |
SRNE ROA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -41.0% | at low | -63.8% | +6.0% |
5 y | 5-year | -98.5% | at low | -154.1% | +6.0% |
alltime | all time | -4580.4% | +92.1% | -4759.6% | +90.7% |
Sorrento Therapeutics ROA History
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | -103.91%(-6.0%) |
Mar 2023 | - | -110.60%(+26.3%) |
Dec 2022 | -98.12%(+41.0%) | -87.56%(+26.0%) |
Sep 2022 | - | -69.50%(-1.4%) |
Jun 2022 | - | -70.51%(+10.5%) |
Mar 2022 | - | -63.81%(+0.6%) |
Dec 2021 | -69.61%(+27.5%) | -63.44%(+17.2%) |
Sep 2021 | - | -54.13%(+3.8%) |
Jun 2021 | - | -52.17%(+27.6%) |
Mar 2021 | - | -40.90%(-24.2%) |
Dec 2020 | -54.59%(+10.4%) | -53.97%(+3.9%) |
Sep 2020 | - | -51.93%(+6.7%) |
Jun 2020 | - | -48.68%(+11.4%) |
Mar 2020 | - | -43.69%(-12.1%) |
Dec 2019 | -49.43%(+28.2%) | -49.69%(+5.8%) |
Sep 2019 | - | -46.98%(+2.6%) |
Jun 2019 | - | -45.78%(-11.1%) |
Mar 2019 | - | -51.47%(+28.1%) |
Dec 2018 | -38.56%(-1860.7%) | -40.18%(+82.6%) |
Sep 2018 | - | -22.00%(+60.5%) |
Jun 2018 | - | -13.71%(>+9900.0%) |
Mar 2018 | - | -0.09%(-104.0%) |
Dec 2017 | 2.19%(-113.4%) | 2.23%(-114.8%) |
Sep 2017 | - | -15.08%(+35.5%) |
Jun 2017 | - | -11.13%(-46.2%) |
Mar 2017 | - | -20.70%(+12.1%) |
Dec 2016 | -16.35%(-13.4%) | -18.47%(-12.7%) |
Sep 2016 | - | -21.15%(-27.6%) |
Jun 2016 | - | -29.22%(+38.2%) |
Mar 2016 | - | -21.14%(-0.8%) |
Dec 2015 | -18.89% | -21.32%(+15.4%) |
Sep 2015 | - | -18.47%(-38.9%) |
Jun 2015 | - | -30.24%(-0.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2015 | - | -30.29%(-5.8%) |
Dec 2014 | -29.61%(-32.9%) | -32.14%(-25.2%) |
Sep 2014 | - | -42.98%(-12.1%) |
Jun 2014 | - | -48.92%(-20.0%) |
Mar 2014 | - | -61.12%(-12.2%) |
Dec 2013 | -44.10%(-48.3%) | -69.63%(-18.2%) |
Sep 2013 | - | -85.14%(-27.6%) |
Jun 2013 | - | -117.66%(+43.9%) |
Mar 2013 | - | -81.76%(+7.6%) |
Dec 2012 | -85.37%(+35.3%) | -75.98%(+12.1%) |
Sep 2012 | - | -67.80%(-0.1%) |
Jun 2012 | - | -67.85%(-17.2%) |
Mar 2012 | - | -81.98%(+16.8%) |
Dec 2011 | -63.11%(+98.5%) | -70.19%(+8.9%) |
Sep 2011 | - | -64.45%(+5.7%) |
Jun 2011 | - | -60.99%(+27.4%) |
Mar 2011 | - | -47.86%(-13.5%) |
Dec 2010 | -31.79%(+19.9%) | -55.36%(-34.4%) |
Sep 2010 | - | -84.38%(+29.2%) |
Jun 2010 | - | -65.32%(+13.7%) |
Mar 2010 | - | -57.44%(+26.1%) |
Dec 2009 | -26.52%(-97.9%) | -45.55%(+288.7%) |
Sep 2009 | - | -11.72%(+2.1%) |
Jun 2009 | - | -11.48%(+84.3%) |
Mar 2009 | - | -6.23%(-72.6%) |
Dec 2008 | - | -22.70%(-82.1%) |
Sep 2008 | - | -126.93%(-40.2%) |
Jun 2008 | - | -212.17%(+48.0%) |
Mar 2008 | - | -143.37%(-74.7%) |
Dec 2007 | -1235.62% | -566.49%(-9.0%) |
Sep 2007 | - | -622.35%(-14.3%) |
Jun 2007 | - | -726.10%(-35.0%) |
Mar 2007 | - | -1117.11% |
FAQ
- What is Sorrento Therapeutics annual return on assets?
- What is the all time high annual ROA for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual ROA year-on-year change?
- What is Sorrento Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly ROA year-on-year change?
What is Sorrento Therapeutics annual return on assets?
The current annual ROA of SRNE is -98.12%
What is the all time high annual ROA for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual return on assets is 2.19%
What is Sorrento Therapeutics annual ROA year-on-year change?
Over the past year, SRNE annual return on assets has changed by -28.51% (-40.96%)
What is Sorrento Therapeutics quarterly return on assets?
The current quarterly ROA of SRNE is -103.91%
What is the all time high quarterly ROA for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly return on assets is 2.23%
What is Sorrento Therapeutics quarterly ROA year-on-year change?
Over the past year, SRNE quarterly return on assets has changed by +6.69% (+6.05%)